The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
GlobalData on MSN7d
Stada strengthens European medicines supply with a new Romanian facilityThe new 100,000 sqm facility required an investment of around $75m. It has an annual production capacity of 150 million packs ...
The Associated Press on MSN13d
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drugThe European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...
must have been filed within 12 months of the earliest corresponding filing on the same drug in the US, the European Union or ...
We recently compiled a list of the 8 Best European Stocks To Buy According to Hedge Funds. In this article, we are going to ...
"We must also resolutely combat the misuse of industrial chemicals as a date rape drug." The European Commission has given ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...
The dual-mechanism drug targets ULBP6, which is secreted by tumor cells and ... during the annual congress of the European ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback